Strategic Analysis of Opportunities in the CRO Market - Phase 0

Table of Contents

1. RESEARCH METHODOLOGY

Research Process

• Scope and Objective

2. INDUSTRY CHALLENGES

Challenges faced by the CROs

• Consolidation within the CRO Industry to Threaten Customer Relationship
• Electronic Data Capture Threatens Revenues
• Risk Sharing Model Necessitates Proper Positioning of Services
• Regional Disparities Affect Competitive Pricing of Services

3. MARKET OVERVIEW

Phase Zero

• CRO Contribution to Drug Development
• Human Microdosing
• Technologies used in Microdosing
• Advantages of Microdosing
• FDA and EMEA Regulations
• The EUMAPP Program
• Concerns about Microdosing
• Revenue Forecasts
• Future Outlook

Profiles of Key Industry Participants

• Accium Biosciences
• Radiant Research
• Vitalea Science
• Xceleron

4. STRATEGIC RECOMMENDATIONS

Approaches to Microdosing

• Alternative Applications of Microdosing

5. DECISION SUPPORT DATABASES

DSD Tables

• Number of Biotech Companies
• Government R&D Investment in Biotechnology
• Percent Government Biotech R & D Investment
• Pharmaceutical R & D Expenditure